Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04919538 · ClinicalTrials.gov registry record
Longitudinal Study for Relapsing Polychondritis
A clinical trial of Vasculitis and Relapsing Polychondritis, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04919538 is a study of Vasculitis and Relapsing Polychondritis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 27,310-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04919538, a study of Vasculitis and Relapsing Polychondritis, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpose of this study is to study the pathogenesis of RP.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04919538
The ClinicalTrials.gov registry entry for NCT04919538 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 27,310-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Vasculitis appearing as the primary indexed condition, and to 0 interventions.
NCT04919538 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04919538 about?
NCT04919538 is a clinical study titled "Longitudinal Study for Relapsing Polychondritis". Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpos...
What is the current status of trial NCT04919538?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-02-26. Estimated completion is 2030-01.
What conditions does trial NCT04919538 study?
This clinical trial studies the following conditions: Vasculitis, Relapsing Polychondritis.
Who is sponsoring clinical trial NCT04919538?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04919538 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasculitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
RECRUITING
-
Vasculitis Pregnancy Registry
RECRUITING
-
Longitudinal Study for Central Nervous System Vasculitis
RECRUITING
-
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.